Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Adrenocortical CarcinomaCushing's Syndrome
Trial Locations (1)

97080

Dept. of Medicine I, University of Wuerzburg, Würzburg

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

lead

University of Wuerzburg

OTHER

NCT00457587 - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma | Biotech Hunter | Biotech Hunter